Randall E. Merchant - Concepedia

Author

Randall E. Merchant

Virginia Commonwealth University Medical Center

Also Known As

Amy Markowitz, Christopher Madden, Michael A. McCrea, Michael McCrea, R E Merchant, R Merchant, R. E. Merchant, R. Merchant, RANDALL E. MERCHANT, Ramon Diaz-Arrastia

170

Publications

5.8K

Citations

H-Index

120

Concepts

All Affiliations

Virginia Commonwealth University Medical Center University of California, San Francisco Virginia Commonwealth University Neurological Surgery University of California San Diego

About

Randall E. Merchant is an author at Virginia Commonwealth University Medical Center specializing in medicine, neurology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.4K
2	Health Sciences	6	6	198
3	Social Sciences	4	4	140
4	Public Health	2	2	49
5	Education	1	1	32

Randall E. Merchant

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study John K. Yue, Esther L. Yuh, Frederick K. Korley, The Lancet Neurology Neuroimaging BiomarkersTraumatic Brain InjuryPlasma Gfap ConcentrationsTrack-tbi CohortNeuroimaging	2019	233
Effect of Citicoline on Functional and Cognitive Status Among Patients With Traumatic Brain Injury Ross Zafonte, Emilia Bagiella, Beth Ansel, JAMA	2012	173
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. D D, Randall E. Merchant, Robert W. Rand, PubMed	1997	147
Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study David O. Okonkwo, Ross C. Puffer, Ava M. Puccio, Journal of Neurotrauma	2020	135
Predicting Long-Term Global Outcome after Traumatic Brain Injury: Development of a Practical Prognostic Tool Using the Traumatic Brain Injury Model Systems National Database William C. Walker, Katharine Stromberg, Jennifer H. Marwitz, Journal of Neurotrauma Traumatic Brain InjuryPrognosisLong-term Global OutcomeGlasgow Outcome ScaleCognitive Rehabilitation	2018	114
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2 Randall E. Merchant, Angus Grant, Lynn Harris Merchant, Cancer Cell TherapyImmunologyKiller CellsHigh-grade GliomasImmunotherapy	1988	109
Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury Esther L. Yuh, Sonia Jain, Xiaoying Sun, JAMA Neurology	2021	104
A Double‐Blind, Placebo‐Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP‐101,606 in Patients with a Mild or Moderate Traumatic Brain Injury Randall E. Merchant, M. Ross Bullock, Cynthia A. Carmack, Annals of the New York Academy of Sciences	1999	103
Intralesional Infusion of Lymphokine-activated Killer (LAK) Cells and Recombinant Interleukin-2 (rIL-2) for the Treatment of Patients with Malignant Brain Tumor Randall E. Merchant, Lynn Harris Merchant, Sallie H. S. Cook, Neurosurgery	1988	94
The Citicoline Brain Injury Treatment (COBRIT) Trial: Design and Methods Ross Zafonte, William T. Friedewald, Shing M. Lee, Journal of Neurotrauma Traumatic Brain InjuryPharmacotherapyBrain Injury RehabilitationCerebral Vascular RegulationStroke Rehabilitation	2009	86

Page 1